UK Police Chiefs Call for Social Media Block on Under16s Over Safety Risks SEC Advances Proposal to End Mandatory Quarterly Earnings Reports Backed by Trump AI Transformation Casts Shadow Over Japans NearRecord Graduate Employment Rate FICO Faces Competitive Pressure as VantageScore Challenges Credit Scoring Dominance Embecta EMBC Faces Target Price Cut Amid Weakening Medtech Sentiment Gilead Sciences GILD Ranked Among Wall Streets Most Profitable Stock Picks with 31 Net Margin and 24 Upside Potential MLAB Q1 2026 Earnings EPS Surges 130 Above Estimates Amid Operational Efficiency Gains GSHD Q1 2026 Earnings Stellar EPS Surprise of 7944 Outpaces Estimates PRH Q1 2026 Earnings FixedIncome Note Rises as Prudential Beats EPS Forecasts MXL Q1 2026 Earnings EPS Surpasses Estimates by 224 Stock Gains Ita Unibanco ITUB Q1 2026 Earnings EPS Misses Estimates as Provisions Weigh on Results Shares Slip 225 CDXS Q1 2026 Earnings Surprise EPS Beat Despite Revenue Uncertainty Metropolitan Bank Holding Corp MCB Edges Higher Amid Consolidation Near Key Resistance Adams Natural Resources Fund PEO Holds Steady Near 2643 After Marginal Gain Alpha Cognition Inc ACOG Edges Higher as Stock Holds Above Key Support Custom Truck One Source CTOS Rallies 118 as Stock Approaches Key Resistance Evolution Global Acquisition Corp Units EVOXU Holds Steady at 1017 Amid Consolidation AZZ Inc AZZ Q1 2026 Earnings EPS Beat Amid Solid Execution Revenue Details Not Disclosed LXP Industrial Trust Q1 2026 Earnings Missed EPS Estimate as Negative Earnings Reported NTRB Q1 2026 Earnings Massive EPS Beat Highlights Cost Control Amid PreRevenue Stage Anteris Technologies Global Corp AVR Q1 2026 Earnings PreRevenue Biotech Posts WiderThanExpected Loss Stock Rallies on Pipeline Optimism AVTR Q1 2026 Earnings EPS Surpasses Estimates Stock Rises 3 DK Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiency Lidl Overtakes Morrisons to Become Fifth Largest Grocer in Great Britain ATO Q1 2026 Earnings EPS Beats Estimates Amidst Operational Discipline Zhengye Biotechnology ZYBT Holds Steady at 087 as Traders Await Catalyst